TrialCurrent Alzheimer research2022

Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial.

Bjoern Schurad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.